Dr Gus Grey is a senior research fellow in the Department of Physiology, University of Auckland, academic director of the Biomedical Imaging Research Unit and principal coordinator of the University’s Mass Spectrometry Hub. He completed his PhD in Auckland before pursuing post-doctoral research in the United States. While in the US he learnt MALDI imaging mass spectrometry at MUSC and Vanderbilt University. He returned to New Zealand at the end of 2009 and acquired MALDI imaging equipment which he now utilises in his own research. His lab aims to use this spatially-resolved technique to understand the basis of ocular lens tissue transparency, the biomolecular changes that take place in cataract formation, and use this knowledge to develop novel therapies to delay or prevent the onset of lens cataract. He also collaborates locally with other researchers to apply MALDI imaging to further understand the pathological processes involved in neurodegeneration, cancer, and even fruit development.

Mark De Hora graduated from the National University of Ireland, Galway with a degree in Science in 1987. He began his career as a Biomedical Scientist in London in 1988 and worked in 4 different London Hospitals. He completed his MSc in Clinical Biochemistry in 1997 when he had his first exposure to GCMS. He began working in the West of England Newborn Screening and Biochemical Genetics laboratory in 2003 specialising in GCMS and LCMSMS investigations for inherited metabolic diseases. He moved to Auckland in 2011 with his family and works for the National Newborn Screening and Biochemical Genetics laboratory at the Starship Hospital in Auckland. Mark has completed the Fellowship of the Royal College of Pathologists Faculty of Science in 2016 and is currently enrolled for PhD programme looking at expanded steroid profiling in bloodspots using high resolution mass spectrometry.

Learn about biomedical imaging Mass spectrometry going on in academia from Dr. Gus Grey and dive deeper into clinical applications of MS with Mr. Mark De Hora in Auckland, New Zealand.

Note this session Date and Time:
Auckland - Jan 26, 4:00pm
Melbourne - Jan 26, 2:00pm
Beijing - Jan 26, 11:00am
Mumbai - Jan 26, 8:30am

Michael Chen did his undergraduate degree in Biochemistry, and subsequently obtained his MD from McGill University. After residency in Laboratory Medicine at McGill, he completed his Master’s Degree (McGill University and University of Victoria) as part of the Clinician Investigator Program in Experimental Medicine with a focus on Clinical Proteomics. He also received fellowship training in clinical lipidology. Michael is also a Medical co-Director at the Victoria Lipid Clinic. Dr Chen’s research interests focus on clinical and translational mass spectrometry. His current medical practice and research emphasizes on the following domains: (1) management of inherited dyslipidemia (2) biomarker verification and validation using mass spectrometry-based technique (3) implementation of mass spectrometry assays in clinical laboratory (4) standardization and utilization of remnant biospecimens for biobanking.

What can do after my degree in mass spectrometry? What is the current state of clinical research and applications in Asia? Join in our inaugural Asia region Fireside Chat as we chat with the MSACL Asia Outreach Committee to learn about their career and hear their thoughts on clinical developments in Asia.